Clinical Trials
9 trialsNCT04037436 2025-04-13
MoveStrong
University of Waterloo
Phase NA Completed
NCT03386812 2021-01-15
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer
University of Texas Southwestern Medical Center
Completed
NCT00063609 2017-09-13
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Novartis
Phase 4 Completed
NCT00925600 2017-05-30
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Phase 3 Completed
NCT01277562 2015-06-08
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer
City of Hope Medical Center
Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00181584 2013-07-11
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT00199537 2008-07-29
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Completed
NCT00228124 2006-01-26
PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition
Ontario Cancer Research Network
Unknown